Related references
Note: Only part of the references are listed.Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group
Massimo Francesco Piepoli et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
A. Doria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
Finnian R. Mc Causland et al.
CIRCULATION (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S. Mackenzie et al.
LANCET (2020)
Uric acid and the cardio-renal effects of SGLT2 inhibitors
Clifford J. Bailey
DIABETES OBESITY & METABOLISM (2019)
Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients
Arrigo Francesco Giuseppe Cicero et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Prognostic value of serum uric acid in patients with acute heart failure A meta-analysis
Gang Huang et al.
MEDICINE (2019)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
Ching-Yen Su et al.
MAYO CLINIC PROCEEDINGS (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dietary Fructose and the Metabolic Syndrome
Marja-Riitta Taskinen et al.
NUTRIENTS (2019)
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
Ulrik M. Mogensen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials
Manal M. Alem
CARDIOVASCULAR THERAPEUTICS (2018)
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinolstudy protocol
Masashi Sakuma et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout
Seoyoung C. Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach
Irving O. Estevez-Garcia et al.
ARTHRITIS CARE & RESEARCH (2018)
Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro
Nathan Robbins et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF ) Study Design
Takashi Yokota et al.
INTERNATIONAL HEART JOURNAL (2018)
Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure
Manal M. Alem et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2018)
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation
Laween Uthman et al.
DIABETOLOGIA (2018)
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials
Yumo Zhao et al.
DIABETES OBESITY & METABOLISM (2018)
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Thomas Bardin et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats
Shinichiro Asakawa et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review
Ching-Wei Tsai et al.
PLOS ONE (2017)
Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2
Daigo Toyoki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Yuliya Lytvyn et al.
CIRCULATION (2017)
Serum Uric Acid level in the severity of Congestive Heart Failure (CHF)
Adnan Khan et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2017)
Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy
Carlos Roncal-Jimenez et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Determinants and Prognostic Impact of Hyperuricemia in Hospitalization for Acute Heart Failure
Wei-Ming Huang et al.
CIRCULATION JOURNAL (2016)
Xanthine Oxidase Inhibitors in Heart Failure Where Do We Go From Here?
Leonardo Tamariz et al.
CIRCULATION (2015)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M. Givertz et al.
CIRCULATION (2015)
Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis
Yu Fan et al.
JOURNAL OF HYPERTENSION (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effects of Allopurinol on Endothehial Dysfunction: A Meta-Analysis
Mehmet Kanbay et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
Yukihiro Chino et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
Dick de Zeeuw et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
Ji Wang et al.
PLOS ONE (2014)
The effects of gout on left atrial volume remodelling: a prospective echocardiographic study
Kuo-Li Pan et al.
RHEUMATOLOGY (2014)
The Crystallization of Monosodium Urate
Miguel A. Martillo et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved Survival
Israel Gotsman et al.
JOURNAL OF CARDIAC FAILURE (2012)
Probenecid: Novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation
Sheryl E. Koch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Allopurinol Acutely Increases Adenosine Triphospate Energy Delivery in Failing Human Hearts
Glenn A. Hirsch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Uric Acid-Induced Endothelial Dysfunction Is Associated with Mitochondrial Alterations and Decreased Intracellular ATP Concentrations
Laura Gabriela Sanchez-Lozada et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Reduced Glomerular Function and Prevalence of Gout: NHANES 2009-10
Eswar Krishnan
PLOS ONE (2012)
Cardiomyocyte NF-kappa B p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure
Tariq Hamid et al.
CARDIOVASCULAR RESEARCH (2011)
Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters
Douglas Greig et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Avosentan for Overt Diabetic Nephropathy
Johannes F. E. Mann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Uric Acid and Long-term Outcomes in CKD
Magdalena Madero et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Uric Acid and Left Ventricular Hypertrophy in Japanese Men
Hirotsugu Mitsuhashi et al.
CIRCULATION JOURNAL (2009)
Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
Rene R. Wenzel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patients
Toshihiro Hamada et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Impact of oxypurinol in patients with symptomatic heart failure
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Relationship of uric acid with progression of kidney disease
Michel Chonchol et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid
Jacob George et al.
CIRCULATION (2006)
J-shaped mortality relationship for uric acid in CKD
Mohamed E. Suliman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients:: La Plata study
Horacio E. Cingolani et al.
JOURNAL OF CARDIAC FAILURE (2006)
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
AV Naumova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure
AD Gavin et al.
HEART (2005)
Oxygen, oxidative stress, hypoxia, and heart failure
FJ Giordano
JOURNAL OF CLINICAL INVESTIGATION (2005)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
A Hoieggen et al.
KIDNEY INTERNATIONAL (2004)
Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy
LB Stull et al.
CIRCULATION RESEARCH (2004)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Hyperuricemia induces a primary renal arteriolapathy in rats by a blood pressure-independent mechanism
M Mazzali et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
TP Cappola et al.
CIRCULATION (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
WS Waring et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts
DA Siwik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Share Paper
